Oxford Researchers Say Their COVID-19 Vaccine Could Be Available in September
Scientists at Oxford University think they have a SARS-CoV-2 vaccine candidate that can jump ahead of those under development at Johnson & Johnson, Moderna, and dozens of smaller biopharmaceutical companies. The current vaccine development record is four years from discovery to approval, but the Jenner Institute team thinks the candidate it has in clinical trials for the could be ready for the public this fall.
The Oxford team's vaccine, which it has dubbed ChAdOx1 nCoV-19, uses an increasingly popular method to deliver therapeutic DNA sequences: a non-replicating adenovirus. ChAdOx1 nCoV-19 and its predecessor, ChAdOx1 MERS, use the same adenovirus to inject genetic blueprints for the spike proteins that give coronaviruses their characteristic shape.
Image source: Getty Images.
Source Fool.com
